These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


366 related items for PubMed ID: 29046324

  • 1. ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population.
    Bastos AU, de Jesus AC, Cerutti JM.
    Eur J Endocrinol; 2018 Jan; 178(1):83-91. PubMed ID: 29046324
    [Abstract] [Full Text] [Related]

  • 2. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children.
    Cordioli MI, Moraes L, Bastos AU, Besson P, Alves MT, Delcelo R, Monte O, Longui C, Cury AN, Cerutti JM.
    Thyroid; 2017 Feb; 27(2):182-188. PubMed ID: 27849443
    [Abstract] [Full Text] [Related]

  • 3. RET, NTRK, ALK, BRAF, and MET Fusions in a Large Cohort of Pediatric Papillary Thyroid Carcinomas.
    Pekova B, Sykorova V, Dvorakova S, Vaclavikova E, Moravcova J, Katra R, Astl J, Vlcek P, Kodetova D, Vcelak J, Bendlova B.
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [Abstract] [Full Text] [Related]

  • 4. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE.
    Cancer; 2016 Apr 01; 122(7):1097-107. PubMed ID: 26784937
    [Abstract] [Full Text] [Related]

  • 5. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer.
    Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, Bogdanova TI, Evdokimova VN, Hatch M, Zurnadzy LY, Nikiforova MN, Yue NJ, Zhang M, Mabuchi K, Tronko MD, Nikiforov YE.
    Cancer; 2014 Mar 15; 120(6):799-807. PubMed ID: 24327398
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y, Yamamoto H, Iwasaki T, Sato M, Jiromaru R, Hongo T, Yasumatsu R, Oda Y.
    Hum Pathol; 2020 Dec 15; 106():82-92. PubMed ID: 32980422
    [Abstract] [Full Text] [Related]

  • 7. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima.
    Iyama K, Matsuse M, Mitsutake N, Rogounovitch T, Saenko V, Suzuki K, Ashizawa M, Ookouchi C, Suzuki S, Mizunuma H, Fukushima T, Suzuki S, Yamashita S.
    Thyroid; 2017 Jun 15; 27(6):811-818. PubMed ID: 28351223
    [Abstract] [Full Text] [Related]

  • 8. Characterization of thyroid cancer driven by known and novel ALK fusions.
    Panebianco F, Nikitski AV, Nikiforova MN, Kaya C, Yip L, Condello V, Wald AI, Nikiforov YE, Chiosea SI.
    Endocr Relat Cancer; 2019 Nov 15; 26(11):803-814. PubMed ID: 31539879
    [Abstract] [Full Text] [Related]

  • 9. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
    Chu YH, Wirth LJ, Farahani AA, Nosé V, Faquin WC, Dias-Santagata D, Sadow PM.
    Mod Pathol; 2020 Dec 15; 33(12):2458-2472. PubMed ID: 32737449
    [Abstract] [Full Text] [Related]

  • 10. Investigation of the Relationship Between Radiation Dose and Gene Mutations and Fusions in Post-Chernobyl Thyroid Cancer.
    Efanov AA, Brenner AV, Bogdanova TI, Kelly LM, Liu P, Little MP, Wald AI, Hatch M, Zurnadzy LY, Nikiforova MN, Drozdovitch V, Leeman-Neill R, Mabuchi K, Tronko MD, Chanock SJ, Nikiforov YE.
    J Natl Cancer Inst; 2018 Apr 01; 110(4):371-378. PubMed ID: 29165687
    [Abstract] [Full Text] [Related]

  • 11. A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.
    Hang JF, Chen JY, Kuo PC, Lai HF, Lee TL, Tai SK, Kuo CS, Chen HS, Li WS, Li CF.
    Mod Pathol; 2023 Sep 01; 36(9):100242. PubMed ID: 37307878
    [Abstract] [Full Text] [Related]

  • 12. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAFV600E Mutation.
    Lee SE, Hwang TS, Choi YL, Kim WY, Han HS, Lim SD, Kim WS, Yoo YB, Kim SK.
    Thyroid; 2017 Jun 01; 27(6):802-810. PubMed ID: 28293988
    [Abstract] [Full Text] [Related]

  • 13. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
    Yamamoto H, Yoshida A, Taguchi K, Kohashi K, Hatanaka Y, Yamashita A, Mori D, Oda Y.
    Histopathology; 2016 Jul 01; 69(1):72-83. PubMed ID: 26647767
    [Abstract] [Full Text] [Related]

  • 14. Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.
    Nikitski AV, Rominski SL, Condello V, Kaya C, Wankhede M, Panebianco F, Yang H, Altschuler DL, Nikiforov YE.
    Thyroid; 2019 Oct 01; 29(10):1425-1437. PubMed ID: 31298630
    [Abstract] [Full Text] [Related]

  • 15. AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma.
    Cordioli MI, Moraes L, Carvalheira G, Sisdelli L, Alves MT, Delcelo R, Monte O, Longui CA, Cury AN, Cerutti JM.
    Cancer Med; 2016 Jul 01; 5(7):1535-41. PubMed ID: 27037835
    [Abstract] [Full Text] [Related]

  • 16. Oncogenic alterations in papillary thyroid cancers of young patients.
    Sassolas G, Hafdi-Nejjari Z, Ferraro A, Decaussin-Petrucci M, Rousset B, Borson-Chazot F, Borbone E, Berger N, Fusco A.
    Thyroid; 2012 Jan 01; 22(1):17-26. PubMed ID: 22150560
    [Abstract] [Full Text] [Related]

  • 17. Prediction of EVT6-NTRK3-Dependent Papillary Thyroid Cancer Using Minor Expression Profile.
    Kechin AA, Ivanov AA, Kel AE, Kalmykov AS, Oskorbin IP, Boyarskikh UA, Kharpov EA, Bakharev SY, Oskina NA, Samuilenkova OV, Vikhlyanov IV, Kushlinskii NE, Filipenko ML.
    Bull Exp Biol Med; 2022 Jun 01; 173(2):252-256. PubMed ID: 35737155
    [Abstract] [Full Text] [Related]

  • 18. Identification of a recurrent STRN/ALK fusion in thyroid carcinomas.
    Pérot G, Soubeyran I, Ribeiro A, Bonhomme B, Savagner F, Boutet-Bouzamondo N, Hostein I, Bonichon F, Godbert Y, Chibon F.
    PLoS One; 2014 Jun 01; 9(1):e87170. PubMed ID: 24475247
    [Abstract] [Full Text] [Related]

  • 19. A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma.
    Chou A, Qiu MR, Crayton H, Wang B, Ahadi MS, Turchini J, Clarkson A, Sioson L, Sheen A, Singh N, Clifton-Bligh RJ, Robinson BG, Gild ML, Tsang V, Leong D, Sidhu SB, Sywak M, Delbridge L, Aniss A, Wright D, Graf N, Kumar A, Rathi V, Benitez-Aguirre P, Glover AR, Gill AJ.
    Mod Pathol; 2023 Dec 01; 36(12):100329. PubMed ID: 37716505
    [Abstract] [Full Text] [Related]

  • 20. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
    Sasaki E, Masago K, Fujita S, Suzuki H, Hanai N, Hosoda W.
    Am J Surg Pathol; 2020 Jul 01; 44(7):962-969. PubMed ID: 32205481
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.